Discover AbbVie's strong performance, with immunology growth and undervaluation despite challenges. Click here to read an ...

AbbVie today announced that the European Commission (EC) granted marketing authorization to RINVOQ® (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in adult patients.

BizClik, one of the UK's fastest-growing digital media companies, has published the April 2025 issue of Healthcare Digital. This edition brings together expert commentary, forward-thinking strategies, ...

Why We Love It: When it comes to liquid eyeliners, this pen by Patrick Starr is the MVP. With a marker tip, this liner offers the kind of precision that lets you draw a cat eye sharp enough to cut ...

Rinvoq (upadacitinib) is a prescription drug that works to treat certain inflammatory conditions by decreasing the activity of immune system cells. Your response to this drug may vary based on ...

Ulcers are a painful symptom of Crohn’s disease. Doctors can help you manage them with medical treatment. Lifestyle factors may also help. Crohn’s disease involves inflammation of the ...